Hemangiomas in children. The appearance of hemangiomas


  • The concept of hemangioma
  • The appearance of hemangiomas
  • Factors affecting the growth of hemangiomas

  • The concept of hemangioma

    Hemangioma - a common and non-specific term for a benign tumor of vascular tissue, vascular birthmarks and vascular malformations.

    Hemangiomas occur in 1.1 - 2.6% of allnewborns, and by the end of the first year, this figure increases to 10.1%. Hemangiomas of the skin and mucous membranes - common benign vascular formation, which constitute 50% of soft tissue tumors in children. Girls hemangiomas occur 2-3 times more often than boys.

    The appearance of hemangiomas

    Hemangiomas in children. The appearance of hemangiomasUsually, hemangiomas are detected immediately after birth and much less - for the first two months of life. 75% are children under the age of one year, and half of them - children under 6 months of life.

    Particularly rapid growth of hemangiomas noted in the first six months of a child's life, then the process is slowed down, with the exception of hemangiomas complicated anatomical localization.

    Some hemangiomas, after rapid growth inDuring the first year of life, over the next 5 - 7 years of age can be subjected to reverse spontaneous development. In this regard, some physicians cautions against too active treatment of hemangiomas in children, often only recommending watching.

    Despite the possibility of self-healing and stophemangioma growth, followed by involution, for its further still remains unpredictable. Calculation of spontaneous regression can sometimes be inconsistent, but the loss of time is clearly not for the benefit of the patient. Also it found to regress spontaneously only 6.7% of hemangiomas.

    Factors affecting the growth of hemangiomas

    Despite its benign nature,hemangiomas have features clinically malignant course. Even dot and small vascular tumors in infants may exhibit rapid growth, often reaching large sizes. Provoke the growth of hemangiomas nootropic and vasoactive drugs (nootropil, piracetam, and others), designated infants infants and children for the treatment of brain pathology.

    Leave a reply